Canada Life
NRIX icon

Canada Life’s Nurix Therapeutics NRIX Stock Holding History

Canada Life’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$72K Hold
4,636
– – ﹤0.01% 1721
2025
Q4 		$88K Hold
4,636
– – ﹤0.01% 1728
2025
Q3 		$43K Hold
4,636
– – ﹤0.01% 1823
2025
Q2 		$53K Hold
4,636
– – ﹤0.01% 1826
2025
Q1 		$55K Buy
+4,636
New +$77.5K ﹤0.01% 1852
2024
Q4 		– Sell
-4,876
Closed -$110K – 2055
2024
Q3 		$110K Hold
4,876
– – ﹤0.01% 1855
2024
Q2 		$102K Buy
+4,876
New +$75.9K ﹤0.01% 1873
2023
Q4 		– Sell
-1,891
Closed -$15K – 2204
2023
Q3 		$15K Hold
1,891
– – ﹤0.01% 2175
2023
Q2 		$19K Hold
1,891
– – ﹤0.01% 2159
2023
Q1 		$17K Hold
1,891
– – ﹤0.01% 2239
2022
Q4 		$21K Hold
1,891
– – ﹤0.01% 2248
2022
Q3 		$25K Buy
1,891
+1,119
+145% +$17.7K ﹤0.01% 2225
2022
Q2 		$10K Hold
772
– – ﹤0.01% 2361
2022
Q1 		$11K Hold
772
– – ﹤0.01% 2425
2021
Q4 		$22K Hold
772
– – ﹤0.01% 2361
2021
Q3 		$23K Sell
772
-756
-49% -$23.3K ﹤0.01% 2401
2021
Q2 		$41K Buy
1,528
+888
+139% +$26.1K ﹤0.01% 2327
2021
Q1 		$20K Hold
640
– – ﹤0.01% 2506
2020
Q4 		$21K Buy
+640
New +$21.2K ﹤0.01% 2530

Other funds holding NRIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Canada Life's NRIX Position: Q1 2026 in Review

Canada Life held its Nurix Therapeutics (NRIX) position steady in Q1 2026 at 4,636 shares worth $72K. The position accounts for ﹤0.01% of the portfolio, ranked #1721.

Canada Life first reported a position in NRIX in Q4 2020 and has held it in 19 quarters since. The position peaked at $110K in Q3 2024. 195 funds tracked by Wall St. Rank hold NRIX as of Q1 2026.

  • Canada Life held 4,636 shares of Nurix Therapeutics worth $72K as of Q1 2026.
  • Canada Life left its Nurix Therapeutics share count unchanged in Q1 2026.
  • Nurix Therapeutics made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1721 holding.
  • Canada Life first reported a position in Nurix Therapeutics in Q4 2020 and has held it in 19 quarters since.
  • Canada Life's Nurix Therapeutics position peaked at $110K in Q3 2024.
  • 195 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.